Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse

MC Irizarry, F Soriano, M McNamara… - Journal of …, 1997 - Soc Neuroscience
MC Irizarry, F Soriano, M McNamara, KJ Page, D Schenk, D Games, BT Hyman
Journal of Neuroscience, 1997Soc Neuroscience
The PDAPP transgenic mouse overexpresses human amyloid precursor protein V717F
(PDAPP minigene) and develops age-related cerebral amyloid-β protein (Aβ) deposits
similar to senile plaques in Alzheimer's disease. We find age-related cortical and limbic Aβ
deposition that begins at 8 months and progresses to cover 20–50% of the neuropil in
cingulate cortex, entorhinal cortex, and hippocampus of 18-month-old heterozygotic
animals. The regional patterns of transgene expression and amyloid deposition suggest that …
The PDAPP transgenic mouse overexpresses human amyloid precursor protein V717F (PDAPP minigene) and develops age-related cerebral amyloid-β protein (Aβ) deposits similar to senile plaques in Alzheimer’s disease. We find age-related cortical and limbic Aβ deposition that begins at 8 months and progresses to cover 20–50% of the neuropil in cingulate cortex, entorhinal cortex, and hippocampus of 18-month-old heterozygotic animals. The regional patterns of transgene expression and amyloid deposition suggest that Aβ deposits occur at the terminals of overexpressing neurons. Amyloid deposition is associated with dystrophic neurites and extensive gliosis. However, stereological analysis shows that there is no overt neuronal loss in entorhinal cortex, CA1 hippocampal subfield, or cingulate cortex through 18 months of age. In addition, there is no apparent loss of mRNA encoding neuronal synaptic, cytoskeletal, or metabolic proteins. Thus, widespread Aβ deposition in 18-month-old heterozygotic mice produces neuritic alterations and gliosis without widespread neuronal death.
Soc Neuroscience